Núria Roglans

2.0k total citations
61 papers, 1.7k citations indexed

About

Núria Roglans is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Núria Roglans has authored 61 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 38 papers in Endocrinology, Diabetes and Metabolism and 32 papers in Molecular Biology. Recurrent topics in Núria Roglans's work include Diet, Metabolism, and Disease (36 papers), Liver Disease Diagnosis and Treatment (33 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Núria Roglans is often cited by papers focused on Diet, Metabolism, and Disease (36 papers), Liver Disease Diagnosis and Treatment (33 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Núria Roglans collaborates with scholars based in Spain, United States and Italy. Núria Roglans's co-authors include Juan C. Laguna, Marta Alegret, Rosa María Galán Sánchez, Manuel Vázquez‐Carrera, Laia Vilà, Miguel Baena, Gemma Sangüesa, Tomás Adzet, Elena Sanguino and Manuel Merlos and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Núria Roglans

58 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Núria Roglans Spain 24 860 853 580 517 267 61 1.7k
Seiichiro Kurita Japan 16 612 0.7× 1.1k 1.3× 597 1.0× 733 1.4× 332 1.2× 21 2.1k
Ana González‐Périz Spain 20 376 0.4× 1.1k 1.3× 602 1.0× 717 1.4× 294 1.1× 24 2.4k
Yumie Takeshita Japan 24 508 0.6× 737 0.9× 322 0.6× 398 0.8× 278 1.0× 68 1.5k
Archana Vijayakumar United States 20 710 0.8× 496 0.6× 557 1.0× 980 1.9× 327 1.2× 32 2.1k
Justin A. Fletcher United States 22 389 0.5× 732 0.9× 667 1.1× 550 1.1× 202 0.8× 34 1.6k
Eva Morán‐Salvador Spain 14 326 0.4× 968 1.1× 507 0.9× 653 1.3× 240 0.9× 16 2.0k
Grace M. Meers United States 23 326 0.4× 731 0.9× 805 1.4× 524 1.0× 194 0.7× 46 1.6k
Marta López‐Parra Spain 16 292 0.3× 809 0.9× 366 0.6× 531 1.0× 243 0.9× 22 1.8k
Anthony J. Romanelli United States 8 639 0.7× 922 1.1× 801 1.4× 1000 1.9× 473 1.8× 10 2.2k
Mario Kahn United States 23 924 1.1× 1.4k 1.7× 1.1k 1.8× 1.2k 2.4× 559 2.1× 37 2.9k

Countries citing papers authored by Núria Roglans

Since Specialization
Citations

This map shows the geographic impact of Núria Roglans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Roglans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Roglans more than expected).

Fields of papers citing papers by Núria Roglans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Roglans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Roglans. The network helps show where Núria Roglans may publish in the future.

Co-authorship network of co-authors of Núria Roglans

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Roglans. A scholar is included among the top collaborators of Núria Roglans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Roglans. Núria Roglans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emmanouilidou, Anastasia, Maria Teresa Rodrigo‐Calvo, Cristina Rodrı́guez, et al.. (2025). Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD. Pharmacological Research. 218. 107860–107860.
2.
Roglans, Núria, Marta Alegret, Elisabetta Profumo, et al.. (2024). Sex Differences Affect the NRF2 Signaling Pathway in the Early Phase of Liver Steatosis: A High-Fat-Diet-Fed Rat Model Supplemented with Liquid Fructose. Cells. 13(15). 1247–1247. 4 indexed citations
3.
Sala‐Vila, Aleix, Iolanda Lázaro, José Rodríguez-Morató, et al.. (2023). Adipose Tissue Protects against Hepatic Steatosis in Male Rats Fed a High-Fat Diet plus Liquid Fructose: Sex-Related Differences. Nutrients. 15(18). 3909–3909. 7 indexed citations
4.
Sala‐Vila, Aleix, Iolanda Lázaro, José Rodríguez-Morató, et al.. (2022). KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid. Biomedicines. 10(7). 1517–1517. 16 indexed citations
5.
Roglans, Núria, María I. Panadero, Marta Alegret, et al.. (2022). Bempedoic Acid Restores Liver H2S Production in a Female Sprague-Dawley Rat Dietary Model of Non-Alcoholic Fatty Liver. International Journal of Molecular Sciences. 24(1). 473–473. 5 indexed citations
6.
Sánchez, Rosa María Galán, et al.. (2021). El ácido bempedoico como activador PPARα: Nuevas perspectivas para el tratamiento de la esteatosis hepática en un modelo experimental de rata hembra. Clínica e Investigación en Arteriosclerosis. 34(2). 57–67. 6 indexed citations
7.
Roglans, Núria, Aleix Sala‐Vila, Iolanda Lázaro, et al.. (2020). Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation. Nutrients. 12(11). 3240–3240. 34 indexed citations
8.
Cedó, Lídia, David Santos, Núria Roglans, et al.. (2017). Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake. PLoS ONE. 12(12). e0189834–e0189834. 23 indexed citations
9.
Baena, Miguel, Gemma Sangüesa, Alberto Dávalos, et al.. (2016). Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues. Scientific Reports. 6(1). 26149–26149. 86 indexed citations
10.
Baena, Miguel, Gemma Sangüesa, José María García Beltrán, et al.. (2016). Liquid fructose in Western-diet-fed mice impairs liver insulin signaling and causes cholesterol and triglyceride loading without changing calorie intake and body weight. The Journal of Nutritional Biochemistry. 40. 105–115. 21 indexed citations
11.
Rebollo, Angelita, Núria Roglans, Miguel Baena, et al.. (2014). Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1841(4). 514–524. 39 indexed citations
12.
Pou, Jordi, et al.. (2011). Tissue factor pathway inhibitor 2 is induced by thrombin in human macrophages. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(6). 1254–1260. 20 indexed citations
13.
Vilà, Laia, Núria Roglans, Rosa María Galán Sánchez, et al.. (2010). Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. The Journal of Nutritional Biochemistry. 22(8). 741–751. 82 indexed citations
14.
Roglans, Núria, Laia Vilà, Marta Alegret, et al.. (2007). Impairment of hepatic Stat-3 activation and reduction of PPARα activity in fructose-fed rats. Hepatology. 45(3). 778–788. 179 indexed citations
15.
Vilà, Laia, Núria Roglans, Marta Alegret, et al.. (2007). Hypertriglyceridemia and Hepatic Steatosis in Senescence-Accelerated Mouse Associate to Changes in Lipid-Related Gene Expression. The Journals of Gerontology Series A. 62(11). 1219–1227. 11 indexed citations
16.
Ribas, Vicent, Xavier Palomer, Núria Roglans, et al.. (2005). Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1737(2-3). 130–137. 17 indexed citations
17.
Sanguino, Elena, Núria Roglans, Marta Alegret, et al.. (2003). Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe. Life Sciences. 73(23). 2927–2937. 8 indexed citations
18.
Roglans, Núria. (2002). Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver. Clinical Pharmacology & Therapeutics. 72(6). 692–701. 34 indexed citations
19.
Rodrı́guez, Cristina, Àgatha Cabrero, Núria Roglans, et al.. (2001). Differential induction of stearoyl-CoA desaturase and acyl-CoA oxidase genes by fibrates in HepG2 cells. Biochemical Pharmacology. 61(3). 357–364. 12 indexed citations
20.
Cabrero, Àgatha, Gemma Llaverı́as, Núria Roglans, et al.. (1999). Uncoupling Protein-3 mRNA Levels Are Increased in White Adipose Tissue and Skeletal Muscle of Bezafibrate-Treated Rats. Biochemical and Biophysical Research Communications. 260(2). 547–556. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026